Biotech 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population July 18, 2026
Biotech REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting July 18, 2026
Biotech DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales July 17, 2026
Biotech CPC Biotech Introduces One-Inch Flow Path, Single-Use Sterile Disconnect for Bioprocessing July 15, 2026
Biotech ALZHEIMER’S BLOOD TEST COULD BRING HIGHLY ACCURATE DIAGNOSIS INTO EVERYDAY CLINICAL CARE July 14, 2026
Biotech ALZpath Demonstrates Global Clinical Impact at AAIC 2026, with Proprietary pTau217 Antibody Anchoring 86 Presentations Demonstrating Clinical and Diagnostic Value Across the Translational Pipeline July 13, 2026